Agreement for antiviral biologics low cost production
The antiviral biologic molnupiravir is going to be synthesized in 27
specialized companies for a modest amount of money, and it is going to
supply 105 developing countries
Baxter and Hillrom: advancing healthcare together
Dec. 13, 2021, Baxter completed its acquisition of Hillrom. Together, Baxter and Hillrom intend to harness their shared expertise to better serve...
Highly potent API expansion for Olon Rodano site
A new, highly automated production line, multi-purpose and high containment, suitable for the synthesis of highly active ingredients
IMA AUTOMATION incorporates all the companies of the Group dedicated to...
IMA AUTOMATION, division of the IMA Group, reorganizes its own structure and incorporates all the companies dedicated to industrial automation. With this new step forward, IMA expands its perimeter strenghtening skills and technologies dedicated to advanced automation, with a strong digital accent.